Can Gabapentin be combined with Klonopin (clonazepam)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Gabapentin and Clonazepam (Klonopin) Combination Therapy

The combination of gabapentin and clonazepam (Klonopin) should be used with caution due to increased risk of central nervous system depression, including excessive sedation, dizziness, cognitive dysfunction, and respiratory depression. 1, 2

Safety Concerns

  • The American Geriatrics Society Beers Criteria warns against concurrent use of benzodiazepines (like clonazepam) with gabapentinoids due to increased risk of severe adverse effects 1
  • A systematic review and meta-analysis found that gabapentinoid combinations with CNS depressants significantly increased the risk of dizziness (OR 3.26), cognitive dysfunction (OR 3.13), and respiratory depression (OR 1.71) compared to monotherapy 2
  • The combination may enhance sedative effects, requiring careful dose titration starting with lower doses of each medication 3

Potential Benefits

  • For certain neuropathic pain conditions, combination therapy may provide more effective pain relief than monotherapy alone, though this must be balanced against safety concerns 1, 3
  • When used together, gabapentin and benzodiazepines may require lower doses of each to achieve therapeutic effects 3, 4

Risk Factors and Contraindications

  • Older adults are at particularly high risk for adverse effects from this combination 1
  • Patients with respiratory conditions may be at increased risk for respiratory depression 2
  • Patients with a history of substance use disorder require additional caution due to misuse potential of both medications 5

Dosing Considerations

  • If this combination is deemed necessary:
    • Start with the lowest effective doses of both medications 3
    • Gabapentin typically starts at 100-300 mg at bedtime or 100-300 mg three times daily, with gradual titration 3
    • Dosage adjustments are required for patients with renal insufficiency 3
    • Monitor closely for excessive sedation and other CNS depressant effects 2

Monitoring Recommendations

  • Regular follow-up visits (every few weeks initially) are recommended to assess effectiveness and monitor for side effects 1
  • Assess for signs of excessive sedation, cognitive impairment, and respiratory depression 2
  • Evaluate renal function before initiating gabapentin and adjust dosing accordingly 3

Alternative Options

  • For neuropathic pain, consider alternative combinations with potentially fewer CNS depressant effects:
    • Gabapentin with a tricyclic antidepressant 3, 4
    • Pregabalin as an alternative to gabapentin 3
  • For anxiety or insomnia, consider non-benzodiazepine alternatives 1

Important Precautions

  • Never abruptly discontinue either medication, as this may precipitate withdrawal symptoms 1
  • Avoid concurrent use with other CNS depressants, including alcohol and opioids 1, 2
  • In a nationally representative sample, 58.4% of off-label gabapentin visits listed one or more concomitant CNS depressant medications, raising significant safety concerns 5

The combination of gabapentin and clonazepam should be approached with extreme caution, weighing potential benefits against significant risks of additive CNS depression. Alternative treatment options with better safety profiles should be considered whenever possible.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Considerations for Gabapentin and Valproate Combination Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Combination pharmacotherapy for the treatment of neuropathic pain in adults.

The Cochrane database of systematic reviews, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.